Skip to main content

Spotlight on Chronic Lymphocytic Leukemia (CLL)

May 24, 2023

Spotlight On Chronic Lymphocytic Leukemia (CLL)

We invite you to learn more about:

  • Emerging therapies and clinical trials for CLL
  • Managing side effects
  • Strategies to improve your quality of life

Nicole Lamanna, MD
Associate Attending, Leukemia Service
Director, Chronic Lymphocytic Leukemia Program
Hematologic Malignancies Section
Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/Columbia University Medical Center
New York, NY

Program Support

Support for this program provided by: AbbVie Inc. - BeiGene; Eli Lilly and Company - Pharmacyclics - An AbbVie Company & Janssen Biotech - and the Thomas D. Oxley Fund for CLL Patient Education & Support.

See All Resources

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.